title: Infliximab for Behçet disease with aortic involvement: two novel case reports without concurrent use of immunosuppressive agents or corticosteroids.
authors: Division of Allergy and Rheumatology, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo 104-8560, Japan. rrokutandah1@gmail.com
authors: Ryo
authors: R
authors: Rokutanda
authors: Masato
authors: M
authors: Okada
authors: Kenichi
authors: K
authors: Yamaguchi
authors: Taiki
authors: T
authors: Nozaki
authors: Gautam A
authors: GA
authors: Deshpande
authors: Mitsumasa
authors: M
authors: Kishimoto
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069285:Infliximab; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab